Novavax Expands Matrix-M Adjuvant Deals Through Partnership With Sanofi
Novavax, Inc. of Gaithersburg, Maryland is continuing to move away from relying primarily on direct vaccine sales and is instead focusing more heavily on licensing agreements and corporate partnerships. The company recently expanded deals with pharmaceutical giants Pfizer, Inc. and Sanofi SA as it attempts to build a more stable revenue stream following a sharp […]
Australia Adds New Mental Health Risks to Ozempic and Other Rapid Weight Loss Drugs
The government of Australia has added two new safety warnings about mental health and contraception for the popular GLP-1 agonist drugs like Ozempic designed to facilitate rapid weight loss. The Therapeutic Goods Administration (TGA), which regulates pharmaceutical products for Australia, issued the new safety warnings in December.1 Health professionals say that, while there is no […]
Sanofi Reports Decline in Flu Vaccine Sales
Sanofi SA reported a decline in vaccine sales for the third quarter of 2025, citing reduced vaccination rates and increased pricing competition in Europe and the United States. The company’s legacy vaccine business dropped nearly eight percent to €3.36 billion (US$3.9 billion), while influenza and COVID-19 shot sales fell 17 percent to €1.53 billion (US$1.78 […]
FDA Plans for Expedited Licensure Approval of GSK’s Autism Drug
On Sept. 22, 2025, the U.S. Food and Drug Administration (FDA), in collaboration with the British pharmaceutical company GSK plc, announced plans to fast-track licensure of leucovorin calcium tablets. The drug, which GSK calls Wellcovorin, has long been used to treat anemia and counteract the effects of chemotherapy, The FDA will approve it for use […]
Johnson & Johnson Liable for Nearly $1 Billion in Damages for Cancer-Causing Baby Powder
Earlier this month, a jury in Los Angeles, found Johnson & Johnson, Inc. (J&J) was liable for damages in the amount of $966 million dollars to the family of a long-time consumer of its baby talcum powder. The jury concluded that the pharmaceutical giant was liable for its dangerous talcum powder product which caused the […]
U.S. Withdraws Financial Support from Pharma’s Arm GAVI
The U.S. government has withdrawn a $1.2 billion pledge to the Global Alliance for Vaccines and Immunization (GAVI) originally made by the Biden administration. GAVI, which is officially known as Gavi, The Vaccine Alliance, is a public-private multilateral funding partnership launched in 2000 by the pharmaceutical industry, governments and private institutions and philanthropic organizations to […]